UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
deCODE Discovers Novel Genetic Link Between Pigmentation Traits and Risk of Skin Cancer
Discoveries help to detail how some fair coloring traits contribute to risk of skin cancer; findings will be integrated into the deCODEme™ service Reykjavik, ICELAND, May 18, 2008 – In two papers published today, deCODE scientists and academic colleagues from Europe...
deCODE Discovers Genetic Variants Influencing Bone Mineral Density
Findings underscore deCODE’s ability to identify genetic risk factors in the most complex traits, and have been integrated into the deCODEme™ service Reykjavik, ICELAND, April 29, 2008 – In a paper published today in the New England Journal of Medicine, a team of...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.